3 completed. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow CL-108: new trials by email Literature Review of CL-108 trials Research Report on CL-108
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route CL-108, M366, Placebo - Pain, Nausea | Phase 1 | Completed | Charleston Laboratories, Inc | 40 | 2015-06-01 | 2019-10-14 |
| A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions CL-108, Vicoprofen, Ultracet - Healthy | Phase 1 | Completed | Charleston Laboratories, Inc | 20 | 2014-11-01 | 2017-05-02 |
| A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip CL-108 - Pain, Nausea | Phase 3 | Completed | Charleston Laboratories, Inc | 178 | 2014-10-01 | 2016-11-03 |
Nausea (2) · Pain (2) · Vomiting (2)
Charleston Laboratories, Inc (3)
United States (1)